Together, we science better

genOway offers preclinical models and solutions to bio-pharmaceutical and academic researchers for ultimate predictability.
BRGSF-HIS: latest data on drug safety, tumor biology & efficacy research
Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in humanized BRGSF-HIS preclinical model
A highly potent anti-VISTA antibody KVA12123 - a promising therapy against poorly immunogenic tumors

Ensuring the ultimate predictability of your research

At genOway, we recognize the crucial role that preclinical research plays in the success of new therapies in clinical settings. Our team of experts brings together decades of experience in designing genetically modified models and a profound understanding of biological physiology to provide unmatched preclinical solutions.

Our collaborative approach, rooted in a deep understanding of your specific needs and complemented by our expertise, strives to define the best solution to predict the success of your research. Join us on a journey of scientific advancement for the benefit of human health.

  • 28
    countries worldwide
  • 380
    academic institutions
  • 13
    EU projects
  • 170
    Life Sciences companies
  • 17
    of the Top 20 pharma

Customized models

Explore our service for creating genetically modified mouse, rat, and cell line models perfectly adapted to answer your scientific questions. With an in-depth understanding of your needs, our team of scientific experts, committed to your side, will accompany you throughout this journey.

Learn more
Our latest resources and publications